Pharmaceuticals & Medical Devices

Experience Highlights

• Bristol-Myers Squibb and Sanofi in ending 12 years of product liability litigation regarding their blood thinner drug, Plavix®, without a single trial or settlement payment. The litigation spurred the U.S. Supreme Court's review of critical specific jurisdiction issues and resulted in the landmark decision in BMS v. Superior Court of California.

• Sanofi as national counsel in product liability litigation involving the presence of the nitrosamine NDMA in the heartburn medication Zantac®.

• AstraZeneca as national counsel in a pharmaceutical mass tort litigation involving the diabetes medication Farxiga®.

• Hologic and Cynosure in defeating class certification and obtaining summary judgment in a purported class action regarding the efficacy of the SculpSure® device. 

• ​​​​​​Bayer as national counsel in defending its oral anticoagulant prescription medicine, Xarelto®. The cases were coordinated in an MDL proceeding, as well as coordinated state court proceedings. Based on our successful record of judgments, the companies agreed to a favorable settlement.

• Pfizer as coordinating science counsel, working with national counsel for the science defense, in securing two significant Daubert victories for the client. These victories led to a summary judgment ruling effectively ending the entire birth defect multi-district litigation for Zoloft®.

• AstraZeneca as national counsel in litigation alleging that the company’s proton-pump inhibitor medications Nexium® and Prilosec® cause kidney injuries. MDL No. 2789

• Bristol-Myers Squibb as national counsel and employed novel strategies that led to global settlement of litigation related to Abilify®. 

• Pfizer, Pharmacia & Upjohn, and Wyeth Pharmaceuticals as lead trial counsel, creating, coordinating, and implementing the science defense and handling all phases of litigation for litigation related to several hormone therapy products.